O. A Paevskaya

2 ta ish

Sechenov University

1. Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects

   Mehdi Alidadi, Haniyeh Barzgar, Mohammad Asif Zaman +4

   Sharh maqola20244 iqtibos

   ABIABI:AkademIndex/2026.other.475949

2. CAR-engineered neutrophils derived from induced pluripotent stem cells: a new frontier in cellular immunotherapy

   E. A Nemilostiva, O. A Paevskaya, Shuxrat Boymuradov +2

   MaqolaPluripotent Stem Cells ResearchClinical & Translational Oncology20260 iqtibos

   ABIABI:AkademIndex/2026.article.018185